Lipocine Inc. (LPCN)

Lipocine Statistics

Total Valuation

Lipocine has a market cap or net worth of $18.40 million. The enterprise value is $4.21 million.

Market Cap	18.40M
Enterprise Value	4.21M

Important Dates

The next estimated earnings date is Thursday, May 7, 2026, before market open.

Earnings Date	May 7, 2026
Ex-Dividend Date	n/a

Share Statistics

Lipocine has 7.30 million shares outstanding. The number of shares has increased by 0.48% in one year.

Current Share Class	7.30M
Shares Outstanding	7.30M
Shares Change (YoY)	+0.48%
Shares Change (QoQ)	+4.95%
Owned by Insiders (%)	5.10%
Owned by Institutions (%)	16.02%
Float	6.40M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	9.45
Forward PS	45.80
PB Ratio	1.09
P/TBV Ratio	1.29
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	2.13
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 6.68, with a Debt / Equity ratio of 0.03.

Current Ratio	6.68
Quick Ratio	6.36
Debt / Equity	0.03
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -54.28% and return on invested capital (ROIC) is -36.09%.

Return on Equity (ROE)	-54.28%
Return on Assets (ROA)	-32.81%
Return on Invested Capital (ROIC)	-36.09%
Return on Capital Employed (ROCE)	-71.64%
Weighted Average Cost of Capital (WACC)	10.02%
Revenue Per Employee	$141,191
Profits Per Employee	-$687,679
Employee Count	14
Asset Turnover	0.10
Inventory Turnover	n/a

Taxes

In the past 12 months, Lipocine has paid $200 in taxes.

Income Tax	200
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -17.95% in the last 52 weeks. The beta is 1.09, so Lipocine's price volatility has been similar to the market average.

Beta (5Y)	1.09
52-Week Price Change	-17.95%
50-Day Moving Average	7.27
200-Day Moving Average	4.87
Relative Strength Index (RSI)	30.21
Average Volume (20 Days)	924,992

Short Selling Information

The latest short interest is 143,656, so 1.97% of the outstanding shares have been sold short.

Short Interest	143,656
Short Previous Month	152,351
Short % of Shares Out	1.97%
Short % of Float	2.25%
Short Ratio (days to cover)	1.14

Income Statement

In the last 12 months, Lipocine had revenue of $1.98 million and -$9.63 million in losses. Loss per share was -$1.77.

Revenue	1.98M
Gross Profit	1.98M
Operating Income	-10.37M
Pretax Income	-9.63M
Net Income	-9.63M
EBITDA	-10.31M
EBIT	-10.37M
Loss Per Share	-$1.77

Balance Sheet

The company has $14.93 million in cash and $449,591 in debt, with a net cash position of $14.48 million or $1.98 per share.

Cash & Cash Equivalents	14.93M
Total Debt	449,591
Net Cash	14.48M
Net Cash Per Share	$1.98
Equity (Book Value)	14.48M
Book Value Per Share	2.35
Working Capital	14.35M

Cash Flow

Operating Cash Flow	-9.76M
Capital Expenditures	n/a
Depreciation & Amortization	60,782
Net Borrowing	n/a
Free Cash Flow	-9.76M
FCF Per Share	-$1.34

Margins

Gross Margin	100.00%
Operating Margin	-524.69%
Pretax Margin	-487.04%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

Lipocine does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-0.48%
Shareholder Yield	-0.48%
Earnings Yield	-51.52%
FCF Yield	-52.23%

Analyst Forecast

Price Target	n/a
Price Target Difference	n/a
Analyst Consensus	Hold
Analyst Count	1
Revenue Growth Forecast (5Y)	111.96%
EPS Growth Forecast (5Y)	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

The last stock split was on May 12, 2023. It was a reverse split with a ratio of 1:17.

Last Split Date	May 12, 2023
Split Type	Reverse
Split Ratio	1:17

Scores

Lipocine has an Altman Z-Score of -13.8. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-13.8
Piotroski F-Score	n/a